AAIP

Allergy and Asthma Institute Pakistan

ADF

Asthma Drug Facility

BiPAP

Bilevel positive airways pressure

CME

Continued medical education

CMSs

Central medical stores

COPD

Chronic obstructive pulmonary disease

COVID-19

Coronavirus disease 2019

CPAP

Continuous positive airways pressure

CRD

Chronic respiratory diseases

DALYs

Disability adjusted life years

DOTS

Directly observed treatment, short-course

ED

Emergency Department

EML

Essential Medicines List

EMRO

Eastern Mediterranean Region

FIRS

Forum of International Respiratory Societies

GAAPP

Global Allergy and Airways Patient Platform

GAN

Global Asthma Network

GAR

Global Asthma Report

GARD

Global Alliance against Chronic Respiratory Diseases

GBD

Global Burden of Disease

GEMA

Guía Española para el Manejo del Asma

GINA

Global Initiative for Asthma

GOLD

Global Initiative for Obstructive Lung Diseases

HCC

Healthy Caribbean Coalition

HDI

Human Development Index

ICS

Inhaled corticosteroids

ICS+LABA

Combinations of ICS and LABA

IMSS

Instituto Méxicano de Seguro Social

INSABI

National Instituto de Salud para el Bienestar

ISAA

Iranian Society of Asthma and Allergy

ISAAC

International Study of Asthma and Allergies in Childhood

ISSSTE

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

KSA

Kingdom of Saudi Arabia

LABA

Long-acting β2-agonist

LMICs

Low- and middle-income countries

LTRA

Leukotriene receptor antagonists

MDI

Metered dose inhaler

MHE

Ministry of Higher Education

MIA

Manejo Integral del Asma

MOH

Ministry of Health

NACP

National Asthma Control Program

NCD

Non-communicable disease

NGOs

Non-governmental organisations

NO2

Nitrogen dioxide

NRAD

National Review of Asthma Deaths

NZ

New Zealand

OCS

Oral corticosteroids

OR

Odds ratios

oSABA

Oral SABA

PACK

Package of Care Kit

PAL

Practical Approach to Lung Disease

PATS

Pan African Thoracic Society

PEN

Package of essential non-communicable disease Interventions for primary health care

PHCs

Public Health Centres

PIPA

Children’s Asthma Prevention Program

PM2.5

Particulate matter 2.5 microns

PTLD

Post-tuberculosis lung disease

r

Rank correlation

RBM

Roll Back Malaria

SABA

Short-acting β2-agonists

SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2

SDG

Sustainable Development Goals

SINA

Saudi Initiative for Asthma

TB

Tuberculosis

The Union

International Union against Tuberculosis and Lung Disease

TRAP

Traffic related air pollution

WAO

World Allergy Organization

WHO

World Health Organization

YLD

Years lived with disability

YLL

Years of life lost

Next: References >